SEGOVA procedure includes - Stem cell therapy, G - Growth factor Platelet Plasma Rich therapy and in Vitro Activation of the ovaries.
Age range
25 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Oocyte presence
Timeframe: 12 months
Changes in Hormone Levels of Follicle-stimulating hormone FSH (mIU/mL)
Timeframe: 12 months
Changes in Hormone Levels of Luteinizing Hormone (mIU/mL)
Timeframe: 12
Changes in Hormone Levels of Estradiol E2 (pg/mL)
Timeframe: 12
Changes in Hormone Levels of Progesterone PG (ng/mL)
Timeframe: 6